cortellis deals intelligence

Women have their say as all-female panel talks biopharma investment, technology trends

This article is part of an ongoing series from Clarivate Analytics celebrating women in STEM with profiles of female scientists, inventors, researchers, and corporate leaders featured in BioWorld, Derwent, Web of Science, and Publons. See more articles in this series, or follow our online campaign using #WomenAtClarivate. One of the hottest tickets in town during […]

Cancer, neurology, immune therapies drive continued robust pace of biopharma financings

2017 was recorded as the second highest financings year for the biopharmaceutical industry. High enthusiasm was demonstrated among investors who funneled about two-thirds of the money through public offerings. BioPharma Financings Reports, 15 separate analyses compiled by BioWorld and Clarivate Analytics focused on key therapeutic markets, found that in addition to cancer companies, firms working […]

Life sciences M&A deals in the fourth quarter of 2017: updates and trends

During the fourth quarter of 2017, Cortellis Deals Intelligence registered 122 new mergers and acquisitions (M&A) with a total disclosed deal value of $92.3 billion as part of its ongoing coverage of M&A activity in the life sciences sector compared to 121 and $30.1 billion in the third quarter and 111 and $22 billion in […]